Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patientsCAZZOLA, Mario; NOSCHESE, Paolo; SALZILLO, Antonello et al.Respiratory medicine. 2005, Vol 99, Num 5, pp 524-528, issn 0954-6111, 5 p.Article

Efficacy and tolerability of formoterol turbuhaler® in childrenVON BERG, A; SAXONI, F. Papageorgiou; WILLE, S et al.International journal of clinical practice (Esher). 2003, Vol 57, Num 10, pp 852-856, issn 1368-5031, 5 p.Article

Total reversibility testing as indicator of the clinical efficacy of formoterol in COPDMOLIMARD, Mathieu; BOURCEREAU, Jacques; LE GROS, Vincent et al.Respiratory medicine. 2005, Vol 99, Num 6, pp 695-702, issn 0954-6111, 8 p.Article

Validation of a RP-HPLC method for the assay of formoterol and its related substances in formoterol fumarate dihydrate drug substanceAKAPO, Samuel O; ASIF, Muhammad.Journal of pharmaceutical and biomedical analysis. 2003, Vol 33, Num 5, pp 935-945, issn 0731-7085, 11 p.Article

Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPDCAZZOLA, M; NOSCHESE, P; DE MICHELE, F et al.Respiratory medicine. 2006, Vol 100, Num 2, pp 212-217, issn 0954-6111, 6 p.Article

Inhibition of mast cell PGD₂ release protects against mannitol-induced airway narrowingBRANNAN, J. D; GULLIKSSON, M; ANDERSON, S. D et al.The European respiratory journal. 2006, Vol 27, Num 5, pp 944-950, issn 0903-1936, 7 p.Article

Budesonide/formoterol effects on metalloproteolytic balance in TGFβ-activated human lung fibroblastsTODOROVA, Lizbet; GÜRCAN, Eylem; WESTERGREN-THORSSON, Gunilla et al.Respiratory medicine. 2009, Vol 103, Num 11, pp 1755-1763, issn 0954-6111, 9 p.Article

A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPDCAZZOLA, M; SANTUS, P; MATERA, M. G et al.Respiratory medicine. 2003, Vol 97, Num 5, pp 458-462, issn 0954-6111, 5 p.Article

Le médicament du mois : Le formotérol (Oxis® Turbohaler®) = Formoterol (Oxis® Turbohaler®)SCHEEN, A. J.RMLG. Revue médicale de Liège. 1998, Vol 53, Num 11, pp 715-718, issn 0370-629XArticle

Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPDCAZZOLA, M; SANTUS, P; DI MARCO, F et al.Respiratory medicine. 2003, Vol 97, Num 5, pp 453-457, issn 0954-6111, 5 p.Article

Anticachectic effects of formoterol: A drug for potential treatment of muscle wastingBUSQUETS, Silvia; FIGUERAS, Maria T; FUSTER, Gemma et al.Cancer research (Baltimore). 2004, Vol 64, Num 18, pp 6725-6731, issn 0008-5472, 7 p.Article

On the mechanism of the persistent action of salmeterol: what is the current position?COLEMAN, R. A.British journal of pharmacology. 2009, Vol 158, Num 1, pp 180-182, issn 0007-1188, 3 p.Article

Effect of indacaterol, a novel long-acting β₂-agonist, on isolated human bronchiNALINE, E; TRIFILIEFF, A; FAIRHURST, R. A et al.The European respiratory journal. 2007, Vol 29, Num 3, pp 575-581, issn 0903-1936, 7 p.Article

High performance liquid chromatography assay method for simultaneous quantitation of formoterol and budesonide in Symbicort TurbuhalerASSI, K. H; TARSIN, W; CHRYSTYN, H et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 1, pp 325-328, issn 0731-7085, 4 p.Article

Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD. CommentaryCAZZOLA, Mario; RICHTER, Kai; STENGLEIN, Stephan et al.Respiration (Basel). 2006, Vol 73, Num 4, issn 0025-7931, 410-411,414-419 [8 p.]Article

Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthmaKUNA, P; CREEMERS, J. P. H. M; VONDRA, V et al.Respiratory medicine. 2006, Vol 100, Num 12, pp 2151-2159, issn 0954-6111, 9 p.Article

Formoterol used as needed in patients with intermittent or mild persistent asthmaCHUCHALIN, Alexandr; KASI, Milan; BENGTSSON, Thomas et al.Respiratory medicine. 2005, Vol 99, Num 4, pp 461-470, issn 0954-6111, 10 p.Article

Rapid onset of tolerance to beta-agonist bronchodilationHANEY, Sarah; HANCOX, Robert J.Respiratory medicine. 2005, Vol 99, Num 5, pp 566-571, issn 0954-6111, 6 p.Article

Safety of formoterol after cumulative dosing via Easyhaler® and Aerolizer®RANDELL, J; SAARINEN, A; WALAMIES, M et al.Respiratory medicine. 2005, Vol 99, Num 12, pp 1485-1493, issn 0954-6111, 9 p.Article

Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary diseaseBERGER, W. E; NADEL, J. A.Respiratory medicine. 2008, Vol 102, Num 2, pp 173-188, issn 0954-6111, 16 p.Article

Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflationSANTUS, P; CENTANNI, S; VERGA, M et al.Respiratory medicine. 2006, Vol 100, Num 7, pp 1277-1281, issn 0954-6111, 5 p.Article

EXCEL : A randomised trial comparing salmeterol/ fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthmaDAHL, Ronald; CHUCHALIN, Alexander; GOR, Dee et al.Respiratory medicine. 2006, Vol 100, Num 7, pp 1152-1162, issn 0954-6111, 11 p.Article

Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPDO'DONNELL, Denis E; VAN NOORD, Jan A; AUMANN, Joseph L et al.Chest. 2006, Vol 129, Num 3, issn 0012-3692, 501-503,509-517 [12 p.]Article

Safety and tolerability of high-dose formoterol (via Aerolizer®) and salbutamol in patients with chronic obstructive pulmonary diseaseROSENKRANZ, Bernd; ROUZIER, Regine; KRUSE, Matthias et al.Respiratory medicine. 2006, Vol 100, Num 4, pp 666-672, issn 0954-6111, 7 p.Article

Budesonide/formoterol maintenance and reliever therapy : an effective asthma treatment option?VOGELMEIER, C; D'URZO, A; PAUWELS, R et al.The European respiratory journal. 2005, Vol 26, Num 5, pp 819-828, issn 0903-1936, 10 p.Article